Iomeron (Iomeprol)

Iomeprol contains a high density of iodine atoms that absorb X‑ray photons more efficiently than surrounding tissues. When injected, it circulates through the vascular system, increasing X‑ray attenuation of blood and extracellular spaces, which creates a pronounced contrast on the resulting images.

The dose of Iomeron is individualized by the prescribing physician based on the specific imaging modality, the anatomical area to be examined, patient weight, and renal function. No fixed regimen is provided; the healthcare professional calculates the appropriate volume for each procedure.

The safety of Iomeron in pregnancy and lactation has not been definitively established. Because iodinated contrast agents cross the placenta and may be secreted in breast milk, clinicians should weigh potential benefits against risks and consider alternative imaging strategies when possible.

To order Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Iomeron (Iomeprol) is a low‑osmolality, non‑ionic iodinated contrast medium, offering a favorable safety profile compared with high‑osmolality agents. Its iodine concentration provides strong X‑ray attenuation while reducing the incidence of discomfort and adverse reactions relative to older ionic formulations.

Iomeron should be stored at ambient temperature, below 25 °C, in its original container. Protect the solution from direct sunlight, excessive heat and moisture. Do not freeze the product, and avoid vigorous shaking before use to maintain solution integrity.

Iomeron is administered by a trained healthcare professional as an intravenous or intra‑arterial injection. The solution is typically delivered through a peripheral or central venous line, using a power injector or manual bolus, according to the imaging protocol prescribed by the radiologist.

Serious risks include anaphylactoid reactions such as severe allergy or bronchospasm, contrast‑induced acute kidney injury, and thyroid dysfunction due to iodine load. Prompt recognition and management of these events are essential, especially in patients with known renal impairment or thyroid disease.

Iomeron is contraindicated in patients with a documented severe allergy to iodinated contrast media, those with uncontrolled hyperthyroidism, and individuals with a history of severe renal insufficiency where alternative imaging methods are feasible. Clinical judgment should guide use in all other cases.